News
Public · Published
AM Markets Need to Know: U.S.-Canada tariff talks, Anthropic IPO, and mor
Stock index futures were mixed on Tuesday as investors awaited economic data, the Federal Reserve's monetary policy decision, and earnings from major technology companies. Meta priced a $37.5B capital raise, Apple addressed display issues on some $1,999 iPhone Duo devices, and the U.S. and Canada discussed tariff relief.
Published:
Updated:
What happened
Stock index futures were mixed on Tuesday as investors awaited economic data, the Federal Reserve's monetary policy decision, and earnings from major technology companies. Meta priced a $37.5B capital raise, Apple addressed display issues on some $1,999 iPhone Duo devices, and the U.S. and Canada discussed tariff relief.
Confirmed
Global impact / market context
Meta's $37.5B raise, split between common stock and mandatory convertible preferred shares, which means stock that must convert later, increases shares outstanding and could dilute current owners. Apple's screen defect may raise warranty costs and hurt repeat sales if the problem spreads across more devices.
Analyst inference
Mixed futures suggest investors are cautious before the Fed decision and big tech earnings, which can move indexes broadly. The U.S.-Canada tariff talks on steel and autos matter because lower duties would cut costs for manufacturers, while failure would keep up to 50% steel and 25% auto duties in place.
Analyst inference
What to watch
- Meta's offering includes $25 billion of Class A common stock and $12.5 billion of depositary shares tied to mandatory convertible preferred stock, with underwriters granted a 30-day option for up to 37.5 million more depositary shares. Confirmed
- Watch whether the U.S. and Canada reach a tariff relief agreement ahead of the November 3 elections, since the article says a possible deal on steel duties up to 50% and auto duties of 25% is under discussion. Proposed
- Track whether Apple's iPhone Duo screen defect expands beyond the reported cases, because wider replacements through AppleCare would raise costs and could weaken demand after strong preorder interest. Analyst inference